MedPath

Megestrol Acetate

{'@ID': 'inv-da1ad2f6-f8ce-4fd6-b830-23f778e6926e'}

Approved
Approval ID

239dacec-8c96-4f4d-878a-b9681cb390f3

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 20, 2021

Manufacturers
FDA

ATLANTIC BIOLOGICALS CORP.

DUNS: 047437707

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Megestrol Acetate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code17856-0907
Application NumberANDA075671
Product Classification
M
Marketing Category
C73584
G
Generic Name
Megestrol Acetate
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 18, 2021
FDA Product Classification

INGREDIENTS (1)

MEGESTROL ACETATEActive
Quantity: 40 mg in 1 mL
Code: TJ2M0FR8ES
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Megestrol Acetate - FDA Drug Approval Details